Pharmabiz56m
Chugai Pharma to transfer future marketing of anti-cancer agent, Tarceva tablets 25, 100 & 150 in Japan to Cheplapharm
Chugai Pharma to transfer future marketing of anti-cancer agent, Tarceva tablets 25, 100 & 150 in Japan to Cheplapharm: Tokyo Wednesday, January 15, 2025, 10:00 Hrs [IST] Chugai P ...
Pharmabiz1h
Daiichi Sankyo to pay $132.5 million to acquire IP rights for anti-TAMUC1 antibody in DS-3939 from Glycotope
Daiichi Sankyo to pay $132.5 million to acquire IP rights for anti-TAMUC1 antibody in DS-3939 from Glycotope: Tokyo Wednesday, January 15, 2025, 09:00 Hrs [IST] Daiichi Sankyo Com ...
Pharmabiz2h
Drug supply to entire north east may collapse if more time is not given to comply with revised Schedule M: ASSPMA
Peethaambaran Kunnathoor, Chennai Wednesday, January 15, 2025, 08:00 Hrs [IST] ...
Pharmabiz2h
DGFT notifies updated export policy aligned with Finance Act 2024 to boost pharma trade efficiency
DGFT notifies updated export policy aligned with Finance Act 2024 to boost pharma trade efficiency: Shardul Nautiyal, Mumbai Wednesday, January 15, 2025, 08:00 Hrs [IST] In a majo ...
Pharmabiz2h
Healthcare sector rapidly adopting technologies to enhance diagnostics, cybersecurity & revenue cycle management
Healthcare sector rapidly adopting technologies to enhance diagnostics, cybersecurity & revenue cycle management: Nandita Vijayasimha, Bengaluru Wednesday, January 15, 2025, 08:00 ...
Pharmabiz2h
Panel recommends DoP to take steps to improve success rate in NIPERs
Panel recommends DoP to take steps to improve success rate in NIPERs: Gireesh Babu, New Delhi Wednesday, January 15, 2025, 08:00 Hrs [IST] Noting that a large number of students e ...
Pharmabiz2h
THE JAN VISHWAS ACT
Bill, 2023 to remove stringent punishments such as imprisonment from some of the provisions of the Drugs and Cosmetics Act, 1940 and the Pharmacy Act, 1948. The Bill was first introduced in Lok Sabha ...
Pharmabiz2h
Parliamentary panel criticises govt for lapse in implementation of scheme for IVDs
Parliamentary panel criticises govt for lapse in implementation of scheme for IVDs: Gireesh Babu, New Delhi Wednesday, January 15, 2025, 08:00 Hrs [IST] The Parliamentary Standing ...
Pharmabiz12h
Telix enters agreement with Curium Pharma for transfer of marketing and distribution rights for Scintimun
Telix, a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals, announces that it has entered ...
Pharmabiz14h
Telix to buy next-generation therapeutic assets and innovative biologics technology platform from ImaginAb
Telix, a commercial-stage biopharmaceutical company, announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline of next ...
Pharmabiz16h
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a pilot proteomics programme to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, ...
Pharmabiz16h
Rappta Therapeutics enters global license agreement with SpringWorks for a pre-clinical first-in-class molecular glue targeting PP2A
Helsinki, Finland Tuesday, January 14, 2025, 18:00 Hrs [IST] ...